Selected research
Industry Research
High-Throughput Sequencing Technology Industry Research Report 2026
Market perspective
The global High-Throughput Sequencing Technology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the High-Throughput Sequencing Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the High-Throughput Sequencing Technology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the High-Throughput Sequencing Technology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of High-Throughput Sequencing Technology include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global High-Throughput Sequencing Technology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to High-Throughput Sequencing Technology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
High-Throughput Sequencing Technology Market by Company
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
High-Throughput Sequencing Technology Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
High-Throughput Sequencing Technology Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
High-Throughput Sequencing Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High-Throughput Sequencing Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of High-Throughput Sequencing Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High-Throughput Sequencing Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of High-Throughput Sequencing Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Targeted Sequencing
- Whole Exome Sequencing
- Whole Genome Sequencing
Applications
- Hospitals and Clinics
- Biopharma Companies
- Academic & Research Organizations
- Others
Companies covered
- Eurofins Scientific
- Natera
- BGI
- Illumina
- Roche
- LabCorp
- Berry Genomics
- Brooks Life Sciences
- Macrogen
- Personalis
- Novogene
- Genotypic Technology
- Dna Link
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 High-Throughput Sequencing Technology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Targeted Sequencing
- 2.2.3 Whole Exome Sequencing
- 2.2.4 Whole Genome Sequencing
- 2.3 High-Throughput Sequencing Technology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals and Clinics
- 2.3.3 Biopharma Companies
- 2.3.4 Academic & Research Organizations
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 High-Throughput Sequencing Technology Breakdown Data by Type
- 3.1 Global High-Throughput Sequencing Technology Historic Market Size by Type (2021-2026)
- 3.2 Global High-Throughput Sequencing Technology Forecasted Market Size by Type (2027-2032)
4 High-Throughput Sequencing Technology Breakdown Data by Application
- 4.1 Global High-Throughput Sequencing Technology Historic Market Size by Application (2021-2026)
- 4.2 Global High-Throughput Sequencing Technology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global High-Throughput Sequencing Technology Market Perspective (2021-2032)
- 5.2 Global High-Throughput Sequencing Technology Growth Trends by Region
- 5.2.1 Global High-Throughput Sequencing Technology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 High-Throughput Sequencing Technology Historic Market Size by Region (2021-2026)
- 5.2.3 High-Throughput Sequencing Technology Forecasted Market Size by Region (2027-2032)
- 5.3 High-Throughput Sequencing Technology Market Dynamics
- 5.3.1 High-Throughput Sequencing Technology Industry Trends
- 5.3.2 High-Throughput Sequencing Technology Market Drivers
- 5.3.3 High-Throughput Sequencing Technology Market Challenges
- 5.3.4 High-Throughput Sequencing Technology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top High-Throughput Sequencing Technology Players by Revenue
- 6.1.1 Global Top High-Throughput Sequencing Technology Players by Revenue (2021-2026)
- 6.1.2 Global High-Throughput Sequencing Technology Revenue Market Share by Players (2021-2026)
- 6.2 Global High-Throughput Sequencing Technology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of High-Throughput Sequencing Technology Head Office and Area Served
- 6.4 Global High-Throughput Sequencing Technology Players, Product Type & Application
- 6.5 Global High-Throughput Sequencing Technology Manufacturers Established Date
- 6.6 Global High-Throughput Sequencing Technology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America High-Throughput Sequencing Technology Market Size (2021-2032)
- 7.2 North America High-Throughput Sequencing Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America High-Throughput Sequencing Technology Market Size by Country (2021-2026)
- 7.4 North America High-Throughput Sequencing Technology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe High-Throughput Sequencing Technology Market Size (2021-2032)
- 8.2 Europe High-Throughput Sequencing Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe High-Throughput Sequencing Technology Market Size by Country (2021-2026)
- 8.4 Europe High-Throughput Sequencing Technology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific High-Throughput Sequencing Technology Market Size (2021-2032)
- 9.2 Asia-Pacific High-Throughput Sequencing Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific High-Throughput Sequencing Technology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific High-Throughput Sequencing Technology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America High-Throughput Sequencing Technology Market Size (2021-2032)
- 10.2 South America High-Throughput Sequencing Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America High-Throughput Sequencing Technology Market Size by Country (2021-2026)
- 10.4 South America High-Throughput Sequencing Technology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa High-Throughput Sequencing Technology Market Size (2021-2032)
- 11.2 Middle East & Africa High-Throughput Sequencing Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa High-Throughput Sequencing Technology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa High-Throughput Sequencing Technology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Scientific
- 12.1.1 Eurofins Scientific Company Information
- 12.1.2 Eurofins Scientific Business Overview
- 12.1.3 Eurofins Scientific Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.1.4 Eurofins Scientific High-Throughput Sequencing Technology Product Portfolio
- 12.1.5 Eurofins Scientific Recent Developments
- 12.2 Natera
- 12.2.1 Natera Company Information
- 12.2.2 Natera Business Overview
- 12.2.3 Natera Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.2.4 Natera High-Throughput Sequencing Technology Product Portfolio
- 12.2.5 Natera Recent Developments
- 12.3 BGI
- 12.3.1 BGI Company Information
- 12.3.2 BGI Business Overview
- 12.3.3 BGI Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.3.4 BGI High-Throughput Sequencing Technology Product Portfolio
- 12.3.5 BGI Recent Developments
- 12.4 Illumina
- 12.4.1 Illumina Company Information
- 12.4.2 Illumina Business Overview
- 12.4.3 Illumina Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.4.4 Illumina High-Throughput Sequencing Technology Product Portfolio
- 12.4.5 Illumina Recent Developments
- 12.5 Roche
- 12.5.1 Roche Company Information
- 12.5.2 Roche Business Overview
- 12.5.3 Roche Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.5.4 Roche High-Throughput Sequencing Technology Product Portfolio
- 12.5.5 Roche Recent Developments
- 12.6 LabCorp
- 12.6.1 LabCorp Company Information
- 12.6.2 LabCorp Business Overview
- 12.6.3 LabCorp Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.6.4 LabCorp High-Throughput Sequencing Technology Product Portfolio
- 12.6.5 LabCorp Recent Developments
- 12.7 Berry Genomics
- 12.7.1 Berry Genomics Company Information
- 12.7.2 Berry Genomics Business Overview
- 12.7.3 Berry Genomics Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.7.4 Berry Genomics High-Throughput Sequencing Technology Product Portfolio
- 12.7.5 Berry Genomics Recent Developments
- 12.8 Brooks Life Sciences
- 12.8.1 Brooks Life Sciences Company Information
- 12.8.2 Brooks Life Sciences Business Overview
- 12.8.3 Brooks Life Sciences Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.8.4 Brooks Life Sciences High-Throughput Sequencing Technology Product Portfolio
- 12.8.5 Brooks Life Sciences Recent Developments
- 12.9 Macrogen
- 12.9.1 Macrogen Company Information
- 12.9.2 Macrogen Business Overview
- 12.9.3 Macrogen Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.9.4 Macrogen High-Throughput Sequencing Technology Product Portfolio
- 12.9.5 Macrogen Recent Developments
- 12.10 Personalis
- 12.10.1 Personalis Company Information
- 12.10.2 Personalis Business Overview
- 12.10.3 Personalis Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.10.4 Personalis High-Throughput Sequencing Technology Product Portfolio
- 12.10.5 Personalis Recent Developments
- 12.11 Novogene
- 12.11.1 Novogene Company Information
- 12.11.2 Novogene Business Overview
- 12.11.3 Novogene Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.11.4 Novogene High-Throughput Sequencing Technology Product Portfolio
- 12.11.5 Novogene Recent Developments
- 12.12 Genotypic Technology
- 12.12.1 Genotypic Technology Company Information
- 12.12.2 Genotypic Technology Business Overview
- 12.12.3 Genotypic Technology Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.12.4 Genotypic Technology High-Throughput Sequencing Technology Product Portfolio
- 12.12.5 Genotypic Technology Recent Developments
- 12.13 Dna Link
- 12.13.1 Dna Link Company Information
- 12.13.2 Dna Link Business Overview
- 12.13.3 Dna Link Revenue in High-Throughput Sequencing Technology Business (2021-2026)
- 12.13.4 Dna Link High-Throughput Sequencing Technology Product Portfolio
- 12.13.5 Dna Link Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst